Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Deucravacitinib |
Trade Name | Sotyktu |
Synonyms | BMS986165|BMS-986165|BMS 986165 |
Drug Descriptions |
Sotyktu (deucravacitinib) is a selective allosteric TYK2 inhibitor that potentially inhibits tumor cell proliferation (PMID: 36799629). Sotyktu (deucravacitinib) is FDA-approved for use in patients with plaque psoriasis (FDA.gov). |
DrugClasses | |
CAS Registry Number | 1609392-27-9 |
NCIT ID | C174730 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Deucravacitinib | Deucravacitinib | 0 | 0 |
Deucravacitinib + PD-0325901 | Deucravacitinib PD-0325901 | 0 | 0 |